Johnson & Johnson has grown revenue 5.9% a year over three years and 1.9% a year over five, with earnings per share compounding at 20%. Revenue growth, 3-year annual rate: +5.9% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +1.9%, growth has picked up over the last three years. Earnings per share, 3-year rate: +20%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

JNJJohnson & Johnson

HealthcareUSD

$270.09

$167.3552 weeks$273.40

Is it growing?

Is JNJ growing?

Johnson & Johnson has grown revenue 5.9% a year over three years and 1.9% a year over five, with earnings per share compounding at 20%.

+5.9%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +1.9%
Revenue growth, 5-year rate · +5.9% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +20%
Earnings per share, 3-year rate · revenue +5.9% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed